Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Shire Acquires Meritage Pharma

February 24, 2015 8:08 am | News | Comments

Shire has acquired Meritage, a privately-held company, for an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory milestones.

TOPICS:

Jacobs to Design Ireland Biologic Facility for BMS

February 24, 2015 8:03 am | News | Comments

Jacobs Engineering Group has received a contract from Bristol-Myers Squibb Company to provide architectural and engineering services for a new large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland.

TOPICS:

Hazardous Location Air Conditioners for Electrical Enclosures

February 23, 2015 4:09 pm | by Kooltronic,Inc | Product Releases | Comments

The Hazardous Location Series Air Conditioners for electrical enclosures are designed for use in NEC Class I, Division 1 Groups A, B, C & D and Division 2 Groups A, B, C & D locations in conjunction with types X and Z purged enclosures, these units are used where hazardous gases are or may be present, and are also suitable for corrosive environments.

Advertisement

Sagent Pharmaceuticals Initiates Voluntary Recall of Atracurium Besylate Injection

February 23, 2015 2:05 pm | News | Comments

Sagent Pharmaceuticals has announced the voluntary nationwide recall of two lots of Atracurium Besylate Injection, USP, 50mg/5mL single-dose vials (NDC 25021-659-05) and four lots of Atracurium Besylate Injection, USP, 100mg/10mL multi-dose vials (NDC 25021-672-10) manufactured by Emcure Pharmaceuticals Ltd. and distributed by Sagent.

TOPICS:

VA's 'Choice' Program for Health Care Off to Slow Start

February 23, 2015 11:37 am | by MATTHEW DALY, Associated Press | News | Comments

Far fewer veterans than expected are taking advantage of a new law aimed at making it easier for them to get private health care and avoid the long waits that have plagued Department of Veterans Affairs facilities nationwide.

TOPICS:

Governors: No Clear Plan if Health Care Subsidies Fall

February 23, 2015 11:35 am | by STEVE PEOPLES, Associated Press | News | Comments

Millions of people could lose health insurance subsidies in the coming months if the Supreme Court sides with opponents of President Barack Obama's health care overhaul. And one thing was clear this weekend as the nation's governors gathered in Washington: Many of the states that could be affected are not prepared for the potential fallout.

TOPICS:

Tobacco Companies Fighting Over Claims on Smoking's Effects

February 23, 2015 11:31 am | News | Comments

America's biggest tobacco companies say they are ready and willing to pass along factual public health information about cigarettes. But they say they will not go along with being forced to underwrite an ad campaign that would have the companies brand themselves as liars.

TOPICS:

Baxter Selects Bannockburn, IL, Facility as Location for Baxalta Global Headquarters

February 23, 2015 11:21 am | News | Comments

Baxter International announced today that Baxalta Incorporated, the biopharmaceutical company that is expected to separate from Baxter in mid-2015, will be headquartered in Northern Illinois at 1200 Lakeside Drive, Bannockburn, IL.

TOPICS:
Advertisement

Anti-Vaccine Mothers Discuss Their Thinking Amid Backlash

February 23, 2015 8:35 am | by GOSIA WOZNIACKA, Associated Press | News | Comments

One is a businesswoman and an MBA graduate. Another is a corporate vice president. The third is a registered nurse. These three mothers — all of them educated, middle-class professionals — are among the vaccine skeptics who have been widely ridiculed since more than 100 people fell ill in a measles outbreak traced to Disneyland.

TOPICS:

Valeant to Buy Salix for Approximately $10B in Cash

February 23, 2015 8:27 am | by ALEX VEIGA, AP Business Writer | News | Comments

Valeant Pharmaceuticals International Inc. has agreed to buy Salix Pharmaceuticals Ltd. for about $10 billion in cash. The companies said Sunday that their boards of directors approved the transaction, which amounts to about $158 for each of Salix's outstanding shares.

TOPICS:

Alkermes Appoints Senior Vice President of Research, Pharmaceutical and Nonclinical Development

February 23, 2015 8:24 am | News | Comments

Alkermes has appointed Mark Namchuk, Ph.D., as Senior Vice President of Research, Pharmaceutical and Nonclinical Development. Dr. Namchuk will be responsible for advancing the company’s early-stage product pipeline.

TOPICS:

NGM and Merck Announce Agreement to Discover, Develop and Commercialize Novel Biologic Therapeutics

February 23, 2015 8:17 am | News | Comments

NGM Biopharmaceuticals, Inc., a privately-held biotechnology company and Merck announced they have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas.

TOPICS:

Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi and Harvoni in India

February 23, 2015 8:13 am | News | Comments

Mylan announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi and Harvoni for the treatment of chronic hepatitis C, in India.

TOPICS:

Bristol-Myers Squibb to Acquire Flexus Biosciences

February 23, 2015 8:08 am | News | Comments

Bristol-Myers Squibb and Flexus Biosciences announced today the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of Flexus, a privately held biotechnology company focused on the discovery and development of novel anti-cancer therapeutics.

TOPICS:

Lawyer: Teen Infected by 'Superbug' Struggling to Survive

February 20, 2015 2:58 pm | by ALICIA CHANG, AP Science Writer; JOHN ROGERS, AP Science Writer | News | Comments

An 18-year-old student is struggling to survive after he was infected by a "superbug" outbreak tied to contaminated medical instruments at a Los Angeles hospital, his attorney said.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading